BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 2901341)

  • 1. Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach.
    Orskov C; Holst JJ; Nielsen OV
    Endocrinology; 1988 Oct; 123(4):2009-13. PubMed ID: 2901341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional receptors for the insulinotropic hormone glucagon-like peptide-I(7-37) on a somatostatin secreting cell line.
    Fehmann HC; Habener JF
    FEBS Lett; 1991 Feb; 279(2):335-40. PubMed ID: 1672112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum.
    Hansen L; Hartmann B; Mineo H; Holst JJ
    Regul Pept; 2004 Apr; 118(1-2):11-8. PubMed ID: 14759551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon-like peptide-1(7-37)/(7-36)amide is a new incretin.
    Fehmann HC; Göke R; Göke B
    Mol Cell Endocrinol; 1992 May; 85(1-2):C39-44. PubMed ID: 1382025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Porcine pancreastatin has no effect on endocrine secretion from the pig pancreas.
    Holst JJ; Ostenson CG; Harling H; Messell T
    Diabetologia; 1990 Jul; 33(7):403-6. PubMed ID: 1976102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of glucagon-like peptide-I (GLP-I) on hormone secretion from isolated human pancreatic islets.
    Fehmann HC; Hering BJ; Wolf MJ; Brandhorst H; Brandhorst D; Bretzel RG; Federlin K; Göke B
    Pancreas; 1995 Aug; 11(2):196-200. PubMed ID: 7479679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of glucagon-like peptide-I (GLP-I) and galanin in insulin (beta TC-1)- and somatostatin (RIN T3)-secreting cells and evidence that both peptides have no receptors on glucagon (INR1G9)-secreting cells.
    Fehmann HC; Janssen M; Göke B
    Acta Diabetol; 1995 Oct; 32(3):176-81. PubMed ID: 8590787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfection of pancreatic-derived beta-cells with a minigene encoding for human glucagon-like peptide-1 regulates glucose-dependent insulin synthesis and secretion.
    Hui H; Yu R; Bousquet C; Perfetti R
    Endocrinology; 2002 Sep; 143(9):3529-39. PubMed ID: 12193567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-islet regulation of hormone secretion by glucagon-like peptide-1-(7--36) amide.
    Heller RS; Aponte GW
    Am J Physiol; 1995 Dec; 269(6 Pt 1):G852-60. PubMed ID: 8572216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide-1 (GLP-1): a gut hormone of potential interest in the treatment of diabetes.
    Ahrén B
    Bioessays; 1998 Aug; 20(8):642-51. PubMed ID: 9780839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enteroglucagon.
    Holst JJ
    Annu Rev Physiol; 1997; 59():257-71. PubMed ID: 9074764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflow.
    Wettergren A; Wøjdemann M; Holst JJ
    Am J Physiol; 1998 Nov; 275(5):G984-92. PubMed ID: 9815028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is glucagon-like peptide 1 an incretin hormone?
    Nauck MA
    Diabetologia; 1999 Mar; 42(3):373-9. PubMed ID: 10096792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man.
    Wettergren A; Schjoldager B; Mortensen PE; Myhre J; Christiansen J; Holst JJ
    Dig Dis Sci; 1993 Apr; 38(4):665-73. PubMed ID: 8462365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of glucagon-like peptide-1 on gastric somatostatin and gastrin secretion in the rat.
    Eissele R; Koop H; Arnold R
    Scand J Gastroenterol; 1990 May; 25(5):449-54. PubMed ID: 1972810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of glucagon-like peptide-1-(1-37) and -(7-37) and glucagon on islet hormone release from isolated perfused canine and rat pancreases.
    Kawai K; Suzuki S; Ohashi S; Mukai H; Ohmori H; Murayama Y; Yamashita K
    Endocrinology; 1989 Apr; 124(4):1768-73. PubMed ID: 2564338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagonlike peptide I (7-37) actions on endocrine pancreas.
    Weir GC; Mojsov S; Hendrick GK; Habener JF
    Diabetes; 1989 Mar; 38(3):338-42. PubMed ID: 2645190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GLP-1 and GLP-1(7-36) amide: influences on basal and stimulated insulin and glucagon secretion in the mouse.
    Fridolf T; Böttcher G; Sundler F; Ahrén B
    Pancreas; 1991 Mar; 6(2):208-15. PubMed ID: 1886889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GLP-1 (glucagon-like peptide 1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in humans.
    Schjoldager BT; Mortensen PE; Christiansen J; Orskov C; Holst JJ
    Dig Dis Sci; 1989 May; 34(5):703-8. PubMed ID: 2714145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of glucagonlike peptide I-(7-36) on release of insulin, glucagon, and somatostatin by rat pancreatic islet cell monolayer cultures.
    D'Alessio DA; Fujimoto WY; Ensinck JW
    Diabetes; 1989 Dec; 38(12):1534-8. PubMed ID: 2573553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.